Low-dose thalidomide is an effective second-line treatment in cutaneous lupus erythematosus

ISSN： 1471-1753

Source： Journal of Dermatological Treatment, Vol.12, Iss.3, 2001-09, pp. : 145-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thalidomide treatment for hypertrophic cutaneous lupus erythematosus

By Gambini D Carrera C Passoni E Muratori S Berti E Caputo R

Journal of Dermatological Treatment, Vol. 15, Iss. 6, 2004-12 ,pp. : 365-371

Informa Healthcare

Access to resources Recommend Favorite

Ustekinumab in the Treatment of Refractory Chronic Cutaneous Lupus Erythematosus: A Case Report

By Dahl Christine Johansen Claus Kragballe Knud Olesen Anne Braae

Acta Dermato-Venereologica, Vol. 93, Iss. 3, 2013-03 ,pp. : 368-369

Medical Journals Limited

Access to resources Recommend Favorite

A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus

By Tatlican Semih Eren Cemile Atacan Damla Dalgic Umut Canpolat Filiz Eskioglu Fatma

Journal of Dermatological Treatment, Vol. 21, Iss. 5, 2010-09 ,pp. : 322-323

Informa Healthcare

Access to resources Recommend Favorite

Dapsone Hypersensitivity Syndrome in a Patient with Cutaneous Lupus Erythematosus

By Christiansen Julie Tegner Eva Irestedt Magnus

Acta Dermato-Venereologica, Vol. 79, Iss. 6, 1999-10 ,pp. : 482-482

Medical Journals Limited

Access to resources Recommend Favorite

Terbinafine-induced Subacute Cutaneous Lupus Erythematosus

By McKay David Schofield Olivia Benton E. Claire

Acta Dermato-Venereologica, Vol. 84, Iss. 6, 2004-11 ,pp. : 472-474

Medical Journals Limited

Access to resources Recommend Favorite